search
Back to results

Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients (FSHD1)

Primary Purpose

Muscular Dystrophy, Facioscapulohumeral

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Physical training
Control
Sponsored by
Centre Hospitalier Universitaire de Saint Etienne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Muscular Dystrophy, Facioscapulohumeral focused on measuring Muscular Dystrophy, Facioscapulohumeral, Physical training, Exercise

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • facioscapulohumeral dystrophy
  • Being capable of supporting an exercise on ergocycle
  • Social Security regimen affiliated
  • Consent form signed

Exclusion Criteria:

  • Severe cardiac or respiratory insufficiency
  • Cardiac pacemaker
  • Morbid obesity (BMI upper to 35)
  • Anti platelet therapy

Sites / Locations

  • CHU de Grenoble
  • CHU de Saint-Etienne

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Physical training

control

Arm Description

The training will consist in 3 sessions of 35 min of training per week at home on an ergocycle. As a result, lower limb muscles will be mainly solicited. These muscles are heterogeneous in terms of deficiency, but this latter is compatible with cycling. The training will be divided in (i) 2 sessions of 30 min aerobic exercises at a constant but moderate (60% of maximal aerobic power, MAP) intensity followed with 5 sets of 10 revolutions at near-maximal intensity and (ii) an interval-training session. This latter session will consist in 5 min warm-up at 40% MAP followed by 5 times 1 min at 80% MAP (recovery = 4 min at 40% MAP) followed by 5 min of active recovery. Over a 2 to 4 weeks initial period, the program will be conducted in the laboratory or at home under the supervision of a coach. Then a systematic supervision of the sessions by the coach will be performed by phone, by using the heart rate recordings and values of Analogic Visual Scale for pain and fatigue.

None intervention

Outcomes

Primary Outcome Measures

maximal oxygen uptake (VO2max)
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle

Secondary Outcome Measures

Questionnaire of quality of life
"short form 36 health survey questionnaire" SF36
Biopsy
biopsy of the vastus lateralis muscle
maximal oxygen uptake (VO2max)
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Questionnaire of subjective fatigue
Fatigue severity scale (FSS)
nuclear magnetic resonance imaging
In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.

Full Information

First Posted
April 28, 2010
Last Updated
March 31, 2015
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Association Française contre les Myopathies (AFM), Paris, Örebro University, Sweden
search

1. Study Identification

Unique Protocol Identification Number
NCT01116570
Brief Title
Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients
Acronym
FSHD1
Official Title
Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
January 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Association Française contre les Myopathies (AFM), Paris, Örebro University, Sweden

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.
Detailed Description
Our research project aims at establishing a program of physical training that will fulfill the two following conditions: (i) being compatible with the daily professional, social and family activity of the patients so it can be integrated in their life habits and (ii) being intensive enough to induce functional benefits. This experimental work will be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires. This work will be based on a collaboration between the Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine). It is accepted that exercise therapy can be recommended for patients with myopathies but long-term training load still has to be determined for each pathology. In the specific context of facioscapulohumeral dystrophy, we aim at associating the scientific evaluation of physical activity benefits and a therapeutic education of patients in order to contribute to recommendations for physicians and physiotherapists. The purpose of this study is to combine an integrated approach with a better understanding of biological process implicated in this physiological treatment strategy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Muscular Dystrophy, Facioscapulohumeral
Keywords
Muscular Dystrophy, Facioscapulohumeral, Physical training, Exercise

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physical training
Arm Type
Experimental
Arm Description
The training will consist in 3 sessions of 35 min of training per week at home on an ergocycle. As a result, lower limb muscles will be mainly solicited. These muscles are heterogeneous in terms of deficiency, but this latter is compatible with cycling. The training will be divided in (i) 2 sessions of 30 min aerobic exercises at a constant but moderate (60% of maximal aerobic power, MAP) intensity followed with 5 sets of 10 revolutions at near-maximal intensity and (ii) an interval-training session. This latter session will consist in 5 min warm-up at 40% MAP followed by 5 times 1 min at 80% MAP (recovery = 4 min at 40% MAP) followed by 5 min of active recovery. Over a 2 to 4 weeks initial period, the program will be conducted in the laboratory or at home under the supervision of a coach. Then a systematic supervision of the sessions by the coach will be performed by phone, by using the heart rate recordings and values of Analogic Visual Scale for pain and fatigue.
Arm Title
control
Arm Type
Other
Arm Description
None intervention
Intervention Type
Other
Intervention Name(s)
Physical training
Intervention Description
Physical training during 24 weeks
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
No intervention
Primary Outcome Measure Information:
Title
maximal oxygen uptake (VO2max)
Description
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Time Frame
Week 24
Secondary Outcome Measure Information:
Title
Questionnaire of quality of life
Description
"short form 36 health survey questionnaire" SF36
Time Frame
Day 0, Week 6, Week 12, Week 18 and Week 24
Title
Biopsy
Description
biopsy of the vastus lateralis muscle
Time Frame
Day 0 and Week 24
Title
maximal oxygen uptake (VO2max)
Description
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Time Frame
Week 6, Week 12 and Week 18
Title
Questionnaire of subjective fatigue
Description
Fatigue severity scale (FSS)
Time Frame
Day 0, Week 6, Week 12, Week 18 and Week 24
Title
nuclear magnetic resonance imaging
Description
In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.
Time Frame
Inclusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: facioscapulohumeral dystrophy Being capable of supporting an exercise on ergocycle Social Security regimen affiliated Consent form signed Exclusion Criteria: Severe cardiac or respiratory insufficiency Cardiac pacemaker Morbid obesity (BMI upper to 35) Anti platelet therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leonard FEASSON, MD-PhD
Organizational Affiliation
CHU de Saint-Etienne
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Fawzi KADI, MD-PhD
Organizational Affiliation
Orebro University, Sweden
Official's Role
Study Chair
Facility Information:
Facility Name
CHU de Grenoble
City
Grenoble
ZIP/Postal Code
38000
Country
France
Facility Name
CHU de Saint-Etienne
City
Saint-etienne
ZIP/Postal Code
42055
Country
France

12. IPD Sharing Statement

Learn more about this trial

Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients

We'll reach out to this number within 24 hrs